Advanced Search
Diliyaer·Tuerhong, Hamulati·Tusong, Asimujiang ·Abula, WANG Yujie. Comparison of Clinical Value of Transrectal Ultrasound, Contrast-enhanced Ultrasonography and Dynamic Contrast Material-enhanced Magnetic Resonance Imaging for Detecting Prostate Carcinoma[J]. Cancer Research on Prevention and Treatment, 2015, 42(09): 915-919. DOI: 10.3971/j.issn.1000-8578.2015.09.012
Citation: Diliyaer·Tuerhong, Hamulati·Tusong, Asimujiang ·Abula, WANG Yujie. Comparison of Clinical Value of Transrectal Ultrasound, Contrast-enhanced Ultrasonography and Dynamic Contrast Material-enhanced Magnetic Resonance Imaging for Detecting Prostate Carcinoma[J]. Cancer Research on Prevention and Treatment, 2015, 42(09): 915-919. DOI: 10.3971/j.issn.1000-8578.2015.09.012

Comparison of Clinical Value of Transrectal Ultrasound, Contrast-enhanced Ultrasonography and Dynamic Contrast Material-enhanced Magnetic Resonance Imaging for Detecting Prostate Carcinoma

More Information
  • Received Date: September 25, 2014
  • Revised Date: March 19, 2015
  • Objective To compare the clinical value of transrectal ultrasound(TRUS), contrast-enhanced ultrasonography(CEUS) and dynamic contrast material-enhanced magnetic resonance imaging(DCE-MRI) for detecting prostate carcinoma. Methods Sixty-three patients were suspected clinically of prostate carcinoma and underwent systematic biopsy further. We retrospectively analyzed the relative test data of TRUS, CEUS and DCE-MRI before operation. The pathological results of biopsy were performed to evaluate the diagnostic value of TRUS, CEUS and DCE-MRI. Results In diagnosing prostate carcinoma, the sensitivity, specificity and accurate rates were 48.84%, 60% and 52.38% with TRUS, 74.42%, 65% and 71.43% with CEUS and 69.77%, 85% and 74.60% with DCE-MRI, retrospectively(P>0.05). Area under ROC curves of TRUS, CEUS, DCE-MRI were 0.550, 0.723, 0.781, and DCE-MRI had the highest sensitivity and accuracy. Conclusion The screening for patients suspected of prostate carcinoma, CEUS and DCE-MRI have higher accuracy than TRUS. The sensitivity and accuracy of DCE-MRI are the highest.
  • [1]
    Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
    [2]
    Center MM, Jemal A, Lortet-Tieulent J, et al. Variation in prostate cancer incidence and mortality rates[J]. Eur Urol, 2012, 61(6): 10 79-92.
    [3]
    Beerlage HP, Aarnink RG, Ruijter ET, et al. Correlation of transrectal ultrasound, computer analysis of transrectal ultrasound and histopathology of radical prostatectomy specimen[J]. Prostate Cancer Prostatic Dis, 2001, 4(1): 56-62.
    [4]
    Rifkin MD, Dahnert W, Kurtz AB. State of the art: endorectal sonography of the prostate gland[J]. AJR Am J Roentgenol, 1990, 15 4(4): 691-700.
    [5]
    Shinohara K, Wheeler TM, Scardino PT. The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations[J]. J Urol, 1989, 142(1): 76 -82.
    [6]
    Delongchamps NB, de la Roza G, Jones R, et al. Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer[J]. BJU Int, 2009, 103(1): 49-54.
    [7]
    Sedelaar JP, van Leenders GJ, Hulsbergen-van de Kaa CA, et al.Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer[J]. Eur Urol, 2001, 40(3): 285-93.
    [8]
    Strohmeyer D, Frauscher F, Klauser A, et al. Contrast-enhanced transrectal color doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer[J]. Anticancer Res, 20 01, 21(4B): 2907-13.
    [9]
    Goldberg BB, Liu JB, Forsberg F. Ultrasound contrast agents: a review[J]. Ultrasound Med Biol, 1994, 20(4): 319-33.
    [10]
    Goldberg BB, Raichlen JS, Forsberg F. Ultrasound contrast agents: basic principles and clinical applications[M]. 2nd edition. London: Martin Dunitz, 2001.
    [11]
    Xie SW, Li HL, Du J, et al. Contrast-enhanced ultrasonography with contrast-tuned imaging technology for the detection of prostate cancer: comparisonwith conventional ultrasonography[J]. BJU Int, 2012, 109(11): 1620-6.
    [12]
    Seitz M, Gratzke C, Schlenker B, et al. Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer[J]. Urol Oncol, 2011, 29(3): 295-301.
    [13]
    Buckley DL, Roberts C, Parker GJ, et al. Prostate cancer: Evaluation of vascular characteristics with dynamic contrastenhanced Tl-weighted MR imaging,initial experience[J]. Radiology, 2004, 233(3): 709-15.
    [14]
    Qiao FL, Yuan JJ, Liu Y, et al. Appliaction value of transrectal ultrasound combined with magnetic resonance imaging in prostate disease[J]. Zhongguo Lao Nian Yi Xue Za Zhi, 2010, 30(9): 11 98-9. [乔峰利, 袁建军, 刘烨, 等. 经直肠超声联合核磁共振 成像在前列腺疾病诊断中的应用价值[J]. 中国老年医学杂志, 20 10, 30(9): 1198 -9.]
    [15]
    Wang XY, Liao MZ, Nong MF, et al. Characteristic of ultrasonography of transrectal and color doppler for diagnosing prostate carcimoma[J]. Zhong Liu Fang Zhi Yan Jiu, 2010, 37(6): 69 6-8. [王小燕, 廖明珠, 农美芬, 等. 前列腺癌径直肠超声及彩 色多普勒特征探讨[J]. 肿瘤防治研究, 2010, 37(6): 696-8.]
    [16]
    Zhao LX, Wu R, Xu G, et al. Comparison of contrast-enhanced ulturasonography with dynamic contrast material-enhanced magnetic resonance imaging for prostate cancer detection[J]. Zhonghua Lin Chuang Yi Shi Za Zhi(Dian Zi Ban), 2013,7(21): 94 53-7. [赵丽霞, 吴蓉, 徐光, 等. 超声造影与磁共振动态增强 成像对前列腺癌的诊断价值比较[J]. 中华临床医师杂志(电子 版) , 2013, 7(21): 9453-7.]
    [17]
    Aigner F, Pallwein L, Schocke M, et al. Comparison of realtime sonoelastography with T2-weighted endorectal magnetic resonance imaging for prostate cancer detection[J]. J Ultrasound Med, 2011, 30(5): 643-9.

Catalog

    Article views (1120) PDF downloads (616) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return